Wex Pharmaceuticals Inc.

81 articles about Wex Pharmaceuticals Inc.

• Wex Pharmaceuticals Inc. Commences Its Quantitative Sensory Testing Clinical Trial Evaluating the Impact of Halneuron(R) on Healthy Volunteers’ Sensory Perceptions

  12/11/2023

  WEX Pharmaceuticals Inc. ("WEX" or the "Company"), a biotechnology company developing Halneuron® (Tetrodotoxin or TTX) for pain, announced that it has commenced its Quantitative Sensory Testing (QST) clinical trial and is actively recruiting participants into this clinical trial.

• Wex Pharmaceuticals Inc. Enrolls the First Patient in The Phase 2b Clinical Trial Evaluating the Efficacy and Safety of Halneuron(R) In the Treatment of Chemotherapy-Induced Neuropathic Pain

  1/3/2023

  WEX Pharmaceuticals Inc., a biotechnology company developing Halneuron® for pain, announced that the first patient has been dosed in its Phase 2B clinical trial evaluating the efficacy and safety of Tetrodotoxin in the treatment of Chemotherapy-Induced Neuropathic Pain.

• Wex Pharmaceuticals Inc. Recommends Acceptance of Increased Offer by Pharmagesic

  1/13/2011

• Wex Pharmaceuticals Inc. Reports Third Quarter Results

  11/15/2010

• Wex Pharmaceuticals Inc. Retirement of Vice President, Research and Development

  10/8/2010

• Wex Pharmaceuticals Inc. Announces Update on Interim Analysis; Data Monitoring Committe Says TEC-006 Clinical Trial Unlikely to Demonstrate a Clinically Meaningful Treatment-Effect

  9/27/2010

• Wex Pharmaceuticals Inc. Announces Poster Presentation at Scientific Conference

  8/26/2010

• Wex Pharmaceuticals Inc. Reports Second Quarter Results

  8/16/2010

• Wex Pharmaceuticals Inc. Receives Unsolicited Proposal to Purchase From Pharmagesic

  7/12/2010

• Wex Pharmaceuticals Inc. Reports First Quarter Results

  5/17/2010

• Wex Pharmaceuticals Inc. Announces Abstract Accepted for Publication

  4/16/2010

• Wex Pharmaceuticals Inc. to Present at BioFinance 2010 Conference

  4/6/2010

• Wex Pharmaceuticals Inc. Reports Year End Financial Results

  2/16/2010

• Wex Pharmaceuticals Inc. Reports Second Quarter Results

  11/13/2009

• Board Changes at Wex Pharmaceuticals Inc.

  10/22/2009

• CK Life Sciences International Increases Equity Stake in Wex Pharmaceuticals Inc.

  10/19/2009

• Wex Pharmaceuticals Inc. to Present at BioContact 2009 Conference

  10/6/2009

• Wex Pharmaceuticals Inc. Reports First Quarter Results

  8/13/2009

• Wex Pharmaceuticals Inc. to Present at BioContact Québec 2008 Conference

  10/1/2008

• Wex Pharmaceuticals Inc. Reports First Quarter Results

  8/14/2008